Spironolactone May Help Treat Chronic Alcoholism

Name: Relias Media
Price range: $

November 30, 2022

Both animal and human studies suggest spironolactone might be a new agent for helping patients with alcohol use disorder cut their intake.

Issue Date: November 30, 2022

Table of Contents

Spironolactone May Help Treat Chronic Alcoholism
Evidence of Clinical Efficacy of Bebtelovimab in COVID-19
Importance of Medication Adherence in Ischemic Heart Disease
Vitamin D3, Omega-3 Supplements for Older Adults to Lower Frailty Risk
Increasing Incidence of Stage IV Cervical Cancer
Deucravacitinib Tablets (Sotyktu)

Dr. Stephen Brunton, physician editor, reports he is on the speakers bureau for AstraZeneca, Bayer, Boehringer Ingelheim, Eli Lilly, and Novo Nordisk; and is a retained consultant for Abbott Diabetes Care, AstraZeneca, Bayer, GSK, and Novo Nordisk. The relevant financial relationships listed have been mitigated. None of the remaining planners or authors for this educational activity have relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Subscription Publication Books & Study Guides Group & Site Licenses State CME/CE Requirements